Article info
PDFLetter
Bevacizumab suppresses choroidal neovascularisation caused by pathological myopia
- Correspondence to: Peter A Campochiaro MD, Maumenee 719, Wilmer Eye Institute, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Baltimore, MD 21287-9277, USA; pcampojhmi.edu
Citation
Bevacizumab suppresses choroidal neovascularisation caused by pathological myopia
Publication history
- Accepted January 14, 2005
- First published September 16, 2005.
Online issue publication
September 16, 2005
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2005 British Journal of Ophthalmology